December 9, 2025 · Form 4 insider transaction
Foundation Fighting Blindness Retinal Degeneration Fund sold 4,000,000 shares of Opus Genetics, Inc. at $2.15 per share, a transaction worth $8.60M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Foundation Fighting Blindness, Inc. ("FFB") is the sole member of Foundation Fighting Blindness Retinal Degeneration Fund ("RDF") and may be deemed to beneficially own the securities owned directly by RDF. RDF has the power to vote and dispose of any securities directly owned by RDF. RDF's board of directors makes voting and investment decisions regarding securities held by RDF, subject to certain approval rights of the board of directors of FFB with respect to transactions exceeding a certain threshold.